Abstract

The Journal of the Ceylon College of Physicians (JCCP) is a peer-reviewed, open access journal published bi-annually by the Ceylon College of Physicians (CCP) in the last week of June and December.The objective of the Journal is to promote good clinical practice and influence policy making across the medical world through publication of original research and peer reviewed articles on current issues and to foster responsible and balanced debate on issues that affect medicine and health care in Sri Lanka. Contributions to the JCCP reflect its national and multidisciplinary readership and include current thinking across a range of medical specialties.

Highlights

  • Erectile dysfunction (ED), the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance[1], is a common problem in patients with diabetes mellitus (DM)[2,3]

  • Sildenafil citrate is an effective drug in the management of erectile dysfunction in patients having diabetes mellitus, with only transient and mild side-effects

  • Method patients with ED attending the Endocrine Clinic at the National Hospital of Sri Lanka (NHSL) were selected after excluding patients taking nitrates, which is an absolute contraindication for sildenafil citrate therapy, and those who had a history of myocardial infarction, unstable angina, stroke or hypotension

Read more

Summary

Introduction

Erectile dysfunction (ED), the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance[1], is a common problem in patients with diabetes mellitus (DM)[2,3]. In Sri Lanka ED is under-diagnosed, as many patients do not divulge this problem and doctors are reluctant to probe this because of personal, environmental and cultural factors. Sildenafil citrate is an effective drug for the management of ED4,5,6. It is a potent and selective phosphodiesterase type 5 inhibitor. It restores erection only with sexual stimulation. The effectiveness of sildenafil citrate for ED in patients having DM varies from 59% to 63% in western studies[2,6]. There are no double blind, placebo controlled clinical trials on sildenafil citrate for patients with DM having ED in Sri Lanka or in southeast Asia

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call